טוען...
A State-of-the-Art Review of New and Emerging Therapies for the Treatment of IBD
Over the last 2 decades, novel therapies targeting several immune pathways have been developed for the treatment of patients with inflammatory bowel disease (IBD). Although anti–tumor necrosis factor (anti-TNF) agents remain the firstline treatment for moderate to severe Crohn’s disease and ulcerati...
שמור ב:
| הוצא לאור ב: | Inflamm Bowel Dis |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6468492/ https://ncbi.nlm.nih.gov/pubmed/30445504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ibd/izy327 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|